Medical Device Manufacturing Centre provides medical device developers and manufacturers with advice, technical expertise, and facilities to translate medical device concepts to commercial products. The MDMC offers services including engineering and manufacturing expertise, business development, clinical and statistical expertise, and regulatory guidance. Self-described as supporting Scottish companies with the transition to small batch commercial prototypes.

Medical Device Manufacturing Centre

Abbott develops and delivers health care technologies and products. The company focuses on various sectors of health care, including diagnostics and nutrition. Self-described as a provider of life-changing solutions.

Abbott

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Don Baxter

Ralph Falk

Thomas Stallkamp

Baxter International Inc.

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Metric
Company Name	Medical Device Manufacturing Centre	Abbott	Baxter International Inc.	Becton, Dickinson and Company
Symbol			BAX	BDX
MSH ID	UK:AC:MDMC	COM:ABBOTT	COM:BAXTER	COM:BD
Market	PRIVATE	PRIVATE	STOCKS	STOCKS
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare	Healthcare
Industry	Medical Device Manufacturing	Medical Devices and Diagnostics	Medical - Instruments & Supplies	Medical - Instruments & Supplies
Country	GB	US	US	US
Stage
Employee Count		10.00K	60K	70K
Website	mdmc.ac.uk	abbott.com	baxter.com	bd.com
LinkedIn				bd1
Founders

Metric
Market Cap		17.45B	64.70B
Enterprise Value
Monthly Web Traffic	873.36K
Web Traffic Growth	-0.14
Valuation
Raised Capital

Metric
Revenue	14.81B	20.18B
Revenue (LTM)
Revenue (NTM)
Gross Profit	4.97B	20.18B
EBITDA	1.75B	2.42B
Operating Income	390M	2.42B
Net Income	2.66B	1.73B
EPS	5.25	5.96
Diluted EPS	5.25	5.93
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.36	0.55
Operating Profit Margin	0.06	0.12
EBITDA Margin	0.12	0.12
Net Profit Margin	0.18	0.07
Return on Equity	0.38	0.06
Return on Assets	0.10	0.03
Return on Capital Employed	0.05	0.05

UK:AC:MDMC

Medical Device Manufacturing Centre

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	7.55	54.49
P/B Ratio	2.41	2.70
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	1.42	3.63
EV Multiple	8.56	15.21

Metric
Days Sales Outstanding	61.33	42.45
Days Payables Outstanding	45.88
Days Inventory Outstanding	113.15	105.52
Operating Cycle	178.17	151.20
Cash Conversion Cycle	130.96	47.37
Asset Turnover	0.57	0.37

Metric
Operating Cash Flow	1.73B	3.84B
Free Cash Flow	1.03B	3.12B
Cash Flow to Debt	0.12	0.21
Operating Cash Flow/Sales	0.12	0.20
Free Cash Flow Yield	0.05	0.04

Metric
Cash & Equivalents	3.19B	1.86B
Accounts Receivable	-66M
Inventory	2.82B	3.84B
Goodwill	6.51B	26.46B
Debt to Capitalization	0.64	0.43
Debt to Assets	0.55	0.33
Current Ratio	1.94	1.08
Quick Ratio	1.01	1.36

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.01	0.01
R&D to Revenue	0.04	0.06
SG&A to Revenue	0.06